ReviewRadiographics : a review publication of the Radiological Society of North America, Inc
Role of US LI-RADS in the LI-RADS Algorithm.
Abstract readReview
In one paragraph
Review in Radiographics : a review publication of the Radiological Society of North America, Inc. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Prevention, surveillance, and early detection of hepatocellular carcinoma - a Brazilian multidisciplinary consensus.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2026Guideline
- Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.The Cochrane database of systematic reviews · 2022Pooled it
- Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.The Cochrane database of systematic reviews · 2021Pooled it
- Clinical utility of 140-degree scan angle wide-view ultrasound for comprehensive liver and spleen imaging.Journal of ultrasound · 2026Article
- Dynamic contrast-enhanced ultrasound with quantitative analysis optimizes LI-RADS for hepatocellular carcinoma diagnosis: a multicenter study.Journal of medical ultrasonics (2001) · 2026Article
- Optimizing US for HCC surveillance.Abdominal radiology (New York) · 2025Review
- Lessons learned: strategies for implementing and the ongoing use of LI-RADS in your practice.Abdominal radiology (New York) · 2025Review
- A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024.Journal of liver cancer · 2025Article
- Review
- Review
- Hepatocellular Carcinoma from a Hepatologist's Perspective.Seminars in interventional radiology · 2023Review
- Assessment of LI-RADS efficacy in classification of hepatocellular carcinoma and benign liver nodules using DCE-MRI features and machine learning.European journal of radiology open · 2023Article
- Incidental Findings in Pediatric Patients: How to Manage Liver Incidentaloma in Pediatric Patients.Cancers · 2023Review
- Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence.Biology · 2023Review
- Current Imaging Diagnosis of Hepatocellular Carcinoma.Cancers · 2022Review
- A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.Diagnostics (Basel, Switzerland) · 2022Review
- Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.AJR. American journal of roentgenology · 2022Article
- Contrast-enhanced ultrasonography for the evaluation of malignant focal liver lesions.Ultrasonography (Seoul, Korea) · 2022Article
- Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients.Frontiers in oncology · 2022Article
- Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.Digestive diseases and sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Shuchi K RodgersFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
David T FetzerFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Helena GabrielFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
James H SeowFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Hailey H ChoiFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Katherine E MaturenFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Ashish P WasnikFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Tara A MorganFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Nirvikar DahiyaFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Mary K O'BoyleFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Yuko KonoFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Claude B SirlinFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Aya KamayaFrom the Department of Radiology, Einstein Medical Center, 5501 Old York Rd, Levy Ground, Philadelphia, PA 19141 (S.K.R.); Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Tex (D.T.F.); Department of Radiology, Northwestern Memorial Hospital, Chicago, Ill (H.G.); Department of Radiology, Royal Perth Hospital, Perth, Australia (J.H.S.); Department of Radiology, Stanford University School of Medicine, Stanford, Calif (H.H.C.); Department of Radiology, University of Michigan Health System, Ann Arbor, Mich (K.E.M., A.P.W.); Department of Radiology and Biomedical Imaging, University of California-San Francisco, San Francisco, Calif (T.A.M.); Department of Radiology, Mayo Clinic, Phoenix, Ariz (N.D.); Department of Radiology (M.K.O., Y.K.) and Liver Imaging Group, Department of Radiology (C.B.S.), University of California-San Diego Medical Center, San Diego, Calif; and Department of Radiology, Stanford University Medical Center, Stanford, Calif (A.K.).
Funding
Molecular Imaging Methods for the Detection of Pancreatic Ductal AdenocarcinomaU01CA210020 · NCI · STANFORD UNIVERSITY · PI IAGARU, ANDREI, PARK, WALTER GWANG-UP · 2017 to 2021
$4.1MThree-Dimensional Multi-Parametric Ultrasound for Monitoring Therapy of Liver MetastasisR01CA195443 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ahmed El Kaffas · 2016 to 2026
$3.6MCONTRAST-ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCCR01CA215520 · NCI · THOMAS JEFFERSON UNIVERSITY · PI LYSHCHIK, ANDREJ · 2017 to 2020
$2.4MNCI NIH HHS R01 CA195443NCI NIH HHS R01 CA215520NCI NIH HHS U01 CA210020
Abstract
The US Liver Imaging Reporting and Data System (LI-RADS) was released in 2017 and is the newest of the four American College of Radiology (ACR) LI-RADS algorithms. US LI-RADS provides standardized terminology, technical recommendations, and a reporting framework for US examinations performed for screening or surveillance in patients at risk for developing hepatocellular carcinoma (HCC). The appropriate patient population for screening and surveillance includes individuals who are at risk for developing HCC but do not have known or suspected cancer. This includes patients with cirrhosis from any cause and subsets of patients with chronic hepatitis B virus infection in the absence of cirrhosis. In an HCC screening or surveillance study, US LI-RADS recommends assigning two scores that apply to the entire study: the US category, which determines follow-up, and a visualization score, which communicates the expected level of sensitivity of the examination but does not affect management. Three US categories are possible: US-1 negative, a study with no evidence of HCC; US-2 subthreshold, a study in which an observation less than 10 mm is depicted that is not definitely benign; and US-3 positive, a study in which an observation greater than or equal to 10 mm or a new thrombus in vein is identified, for which diagnostic contrast material-enhanced imaging is recommended. Three visualization scores are possible: A (no or minimal limitations), B (moderate limitations), and C (severe limitations).
Indexed as
AlgorithmsData SystemsUltrasonographyAgedCarcinoma, HepatocellularEarly Detection of CancerFemaleHumansLiverLiver DiseasesLiver NeoplasmsMaleMiddle AgedPopulation Surveillance
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.